Clinical Trial Update: Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized study investigates long-term radiotherapy with capecitabine followed by XELOX and TME in high-risk rectal cancer to assess outcomes includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine-based long-term radiotherapy (Capecitabine)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Rectal Cancer, Pathological Complete Response | Phase 2 | Status: UNKNOWN